Related Experiment Videos
A case of lithium-chlorpromazine interaction
The Journal of Clinical Psychiatry
|February 1, 1986
Summary
Neurotoxicity occurred in a patient receiving lithium and chlorpromazine for two years, presenting with confusion and movement issues. A low red cell to plasma lithium ratio was observed, suggesting a drug interaction mechanism.
Area of Science:
- Neuroscience
- Pharmacology
- Clinical Toxicology
Background:
- Lithium is a common treatment for bipolar disorder.
- Chlorpromazine is an antipsychotic medication.
- Drug interactions can alter therapeutic efficacy and toxicity.